The Latest Breaking News from Nasdaq

NVIDIA Corporation (NASDAQ:NVDA) agreed to settle civil charges for inadequate disclosure of the impact of crypto mining on its gaming business. The chipmaker will pay $5.5 million to the U.S. SEC for misleading investors and analysts interested in understanding the impact of crypto mining on Nvidia's business. Despite having information, Nvidia failed to…

Draftkings, Inc (NASDAQ: DKNG) hit near to the 52-week low of $13.06 again on Friday but began to bounce up from the level at 10 a.m. when the S&P 500 began to make a reversal from its low-of-day price.

The U.K. government is planning to launch a new regulatory agency that oversees major tech companies, but the launch and dimensions of this agency remain unclear.

Someone with a lot of money to spend has taken a bearish stance on Amazon.com (NASDAQ:AMZN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Someone with a lot of money to spend has taken a bearish stance on Meta Platforms (NASDAQ:FB). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Goodyear Tire & Rubber Co (NASDAQ:GT) reported first-quarter FY22 net sales growth of 39.8% year-on-year to $4.91 billion, beating the consensus of $4.65 billion. Cooper Tire merger, improvements in price/mix, higher volume, and increased sales from other tire-related businesses drove the growth. Sales in the Americas rose 63% Y/Y, Europe, Middle East &…

ChemoCentryx Inc (NASDAQ: CCXI) shares are trading higher by 21.45% at $19.00 after the company reported first-quarter results.

LENSAR (NASDAQ:LNSR) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that LENSAR will report an earnings per share (EPS) of $-0.73.

BioXcel Therapeutics (NASDAQ:BTAI) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that BioXcel Therapeutics will report an earnings per share (EPS) of $-1.15.

R1 RCM (NASDAQ:RCM) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that R1 RCM will report an earnings per share (EPS) of $0.10.

Profound Medical (NASDAQ:PROF) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Profound Medical will report an earnings per share (EPS) of $-0.43.